Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702287 | Practical Radiation Oncology | 2017 | 14 Pages |
Abstract
Our results suggest that ABC reduces IMN coverage in left-sided breast cancer patients planned for PMRT; however, dosimetric criteria for IMN coverage were still met, suggesting that this is not likely to be clinically significant. ABC led to significant sparing of organs at risk compared with FB conditions and was not affected by BMI. Collectively, the results support the use of ABC for breast cancer patients undergoing left-sided PMRT requiring regional nodal irradiation that includes the IMNs. Further prospective clinical studies are required to determine the impact of these results on late normal tissue effects.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Aisling MD, Kathy MD, Claudio MD, PhD, Mohammad MBBS, Melania MSc, Grace MRT(T), CMD, MHSc, Anthony MD, C. Anne MD, PhD,